Table 3.
Yearly prevalence and annual transition of number of RIF women with CE and MDR-CE
Year* | 2010–2011 | 2011–2012 | 2012–2013 | 2013–2014 | 2014–2015 | 2015–2016 | 2016–2017 | 2017–2018 | 2018–2019 | 2019–2020 | Net |
---|---|---|---|---|---|---|---|---|---|---|---|
Whole CE | 13 | 35 | 41 | 57 | 91 | 137 | 149 | 178 | 192 | 189 | 1082 |
MDR-CE | 1 | 0 | 0 | 1 | 1 | 7 | 11 | 15 | 22 | 26 | 84 |
*From April to March